Information Provided By: 
Fly News Breaks for April 23, 2018
IONS, BIIB
Apr 23, 2018 | 07:36 EDT
Citi analyst Robyn Karnauskas believes Biogen's (BIIB) collaboration expansion with Ionis Pharmaceuticals (IONS) is a smart deal. The deal gives Biogen access to a number of new drug targets, Karnauskas tells investors in a research note. Further, the analyst notes that Biogen still has the financial flexibility after this transaction to enter further partnerships or do acquisitions. She keeps a Neutral rating on shares of Biogen.
News For BIIB;IONS From the Last 2 Days
There are no results for your query BIIB;IONS
